Russell Frank Company’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Russell Frank Company’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$609K	Buy	+9,504	New	+$769K	﹤0.01%	2385

Other funds holding KDNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Russell Frank Company's KDNY Position: Q1 2016 in Review

Russell Frank Company opened a new position in Chinook Therapeutics, Inc. Common Stock (KDNY) in Q1 2016: 9,504 shares worth $609K. The stake represents ﹤0.01% of the portfolio and ranks #2385 among its holdings.

89 funds tracked by Wall St. Rank hold KDNY as of Q1 2016.

Russell Frank Company held 9,504 shares of Chinook Therapeutics, Inc. Common Stock worth $609K as of Q1 2016.
Chinook Therapeutics, Inc. Common Stock was a new Russell Frank Company position in Q1 2016.
Chinook Therapeutics, Inc. Common Stock made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2385 holding.
89 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.